AbbVie Inc. is 263.5x more valuable than ANAPTYSBIO, INC by market capitalization ($399.47 B vs $1.52 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ANAB | ABBV |
|---|---|---|
| Market cap | $1.52 B | $399.47 B |
| US-listed rank | #2310 | #28 |
| Revenue (latest FY) | $234.60M | $61.16B |
| Net income (latest FY) | -$13.23M | $4.23B |
| Net margin | -5.6% | 6.9% |
| P/E (trailing FY) | - | 94.5 |
| SEC filings | 681 | 1,008 |
AbbVie Inc. is 263.5x more valuable than ANAPTYSBIO, INC by market capitalization ($399.47 B vs $1.52 B).
In their latest fiscal years, ANAPTYSBIO, INC reported $234.60M in revenue while AbbVie Inc. reported $61.16B.
Full pages: ANAPTYSBIO, INC and AbbVie Inc., or browse the full rankings.